nicotinamide thiglycolate esters (Syntrix Biosystems)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namenicotinamide thiglycolate esters (Syntrix Biosystems)
Drug Alias Namechemokine receptor-2 inhibitors (Syntrix Biosystems)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-X-C motif chemokine receptor 2 agonists
TargetsC-X-C motif chemokine receptor 2
Therapy Area/IndicationsLung MalformationInflammatory Bowel DiseasesArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSyntrix Biosystems Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSyntrix Biosystems Inc
Active IndicationsN/A
Inactive IndicationsLung MalformationInflammatory Bowel DiseasesArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A